PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 204 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $358,000 | +62.7% | 15,010 | +84.8% | 0.29% | +97.3% |
| Q2 2019 | $220,000 | -32.9% | 8,124 | -34.0% | 0.15% | +2.1% |
| Q3 2018 | $328,000 | -69.4% | 12,308 | -56.6% | 0.14% | -57.9% |
| Q2 2018 | $1,071,000 | +104.4% | 28,362 | +192.4% | 0.34% | +129.7% |
| Q3 2017 | $524,000 | +5.6% | 9,700 | -53.8% | 0.15% | -38.6% |
| Q2 2016 | $496,000 | -9.3% | 21,000 | -21.6% | 0.24% | -34.2% |
| Q1 2016 | $547,000 | – | 26,800 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |